Eric Fain
Director/Board Member bij ORCHESTRA BIOMED HOLDINGS, INC.
Vermogen: 156 872 $ op 31-03-2024
Profiel
Eric S.
Fain is currently the President, Chief Executive Officer & Director at Procyrion, Inc. He is also a Director at Orchestra BioMed, Inc. and the Lead Non-Executive Director at Orchestra Biomed Holdings, Inc. Previously, Dr. Fain held positions as a Director at CardioKinetix, Inc. and Avertix Medical Systems, Inc. He was also a Senior Vice President at Abbott Laboratories in 2017.
From 2012 to 2014, he served as the President-Implantable Electronic Systems Division at St. Jude Medical LLC.
Prior to that, he was the Vice President-Systems Development at Ventritex, Inc. from 1987 to 1997.
He also worked as a Principal at Boston Scientific Corp.
and as the President of Cardiac Rhythm Management.
Dr. Fain received his undergraduate degree from Brown University and his doctorate from Stanford University School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
22-03-2024 | 29 767 ( 0.08% ) | 156 872 $ | 31-03-2024 |
Actieve functies van Eric Fain
Bedrijven | Functie | Begin |
---|---|---|
ORCHESTRA BIOMED HOLDINGS, INC. | Director/Board Member | 26-01-2023 |
Procyrion, Inc.
Procyrion, Inc. Medical SpecialtiesHealth Technology Procyrion, Inc. manufactures medical devices. The firm develops percutaneous circulatory assist device intended to treat chronic heart failure. Its product Aortix is a catheter deployed circulatory assist device for the millions of heart failure patients who are too sick for medication alone. The company was founded by Reynolds M. Delgado III in 2005 and is headquartered in Houston, TX. | Chief Executive Officer | 30-07-2018 |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Director/Board Member | 01-11-2018 |
Eerdere bekende functies van Eric Fain
Bedrijven | Functie | Einde |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 01-07-2017 |
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Ventritex, Inc. designs, develops, manufactures and markets implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation. | Corporate Officer/Principal | - |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Director/Board Member | - |
Cardiac Rhythm Management
Cardiac Rhythm Management Medical SpecialtiesHealth Technology Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a private company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA. | President | - |
Opleiding van Eric Fain
Brown University | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Distribution Services |
ORCHESTRA BIOMED HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
St. Jude Medical LLC
St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Ventritex, Inc. designs, develops, manufactures and markets implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation. | Health Technology |
Procyrion, Inc.
Procyrion, Inc. Medical SpecialtiesHealth Technology Procyrion, Inc. manufactures medical devices. The firm develops percutaneous circulatory assist device intended to treat chronic heart failure. Its product Aortix is a catheter deployed circulatory assist device for the millions of heart failure patients who are too sick for medication alone. The company was founded by Reynolds M. Delgado III in 2005 and is headquartered in Houston, TX. | Health Technology |
Cardiac Rhythm Management
Cardiac Rhythm Management Medical SpecialtiesHealth Technology Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a private company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA. | Health Technology |
CardioKinetix, Inc.
CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Distribution Services |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Health Technology |